Evidence map›Paper›PMID 35163588›Full record

ArticleInternational journal of molecular sciences2022

The

Arun Mouli Kolinjivadi, Haresh Sankar, Ramveer Choudhary, Lavina Sierra Tay, Tuan Zea Tan, Naoko Murata-Kamiya, Dominic Chih-Cheng Voon, Dennis Kappei, Masanori Hatakeyama, Vaidehi Krishnan and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. World journal of hepatology · 2025
    Article
  2. Diseases (Basel, Switzerland) · 2024
    Review
  3. A review for non-antibiotic treatment ofFrontiers in microbiology · 2024
    Review
  4. Binding of YY1/CREB to an Enhancer Region Triggers Claudin 6 Expression inInternational journal of molecular sciences · 2023
    Article
  5. Review
  6. Article
  7. TheGut microbes
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Arun Mouli KolinjivadiCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
Haresh SankarCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.
Ramveer ChoudharyFIRC Institute of Molecular Oncology (IFOM), 20139 Milan, Italy.ORCID 0000-0002-5340-7854
Lavina Sierra TayGenome Institute of Singapore, Agency for Science, Technology and Research, Singapore 138672, Singapore.ORCID 0000-0003-4072-4591
Tuan Zea TanGenomic and Data Analytics Core (GeDaC), Cancer Science Institute, National University of Singapore, Singapore 117599, Singapore.ORCID 0000-0001-6624-1593
Naoko Murata-KamiyaDepartment of Microbiology, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
Dominic Chih-Cheng VoonInstitute for Frontier Science Initiative, Kanazawa University, Kanazawa 920-1192, Japan.ORCID 0000-0002-2963-9305
Dennis KappeiCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.ORCID 0000-0002-3582-2253
Masanori HatakeyamaDepartment of Microbiology, Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
Vaidehi KrishnanCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.ORCID 0000-0002-5028-6567
Yoshiaki ItoCancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.ORCID 0000-0002-9037-1184
National University of Singapore · SGThe University of Tokyo · JPAgency for Science, Technology and Research · SGIFOM · ITKanazawa University · JP

Funding

Singapore Ministry of Health's National Medical Research Council NMRC/CIRG/1452/2016
6 · The paper itself

Abstract

The proteins from the Fanconi Anemia (FA) pathway of DNA repair maintain DNA replication fork integrity by preventing the unscheduled degradation of nascent DNA at regions of stalled replication forks. Here, we ask if the bacterial pathogen

Indexed as

DNA Breaks, Double-StrandedDNA ReplicationDown-RegulationSignal TransductionAntigens, BacterialBacterial ProteinsCell LineFanconi Anemia Complementation Group ProteinsHelicobacter InfectionsHelicobacter pyloriHumansOncogene ProteinsAntigens, BacterialBacterial ProteinscagA protein, Helicobacter pyloriFanconi Anemia Complementation Group ProteinsOncogene ProteinsCagADNA double strand breaksDNA replicationFanconi AnemiaH. pyloriγH2AX

Identifiers

PMID35163588
PMCPMC8836099
OpenAlexW4210292187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.